Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Casi Pharmaceuticals Inc (NQ: CASI )

2.150 +0.150 (+7.50%)
Streaming Delayed Price Updated: 3:59 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 23,197
Open 2.010
Bid (Size) 2.030 (3)
Ask (Size) 2.150 (2)
Prev. Close 2.000
Today's Range 2.000 - 2.190
52wk Range 1.450 - 3.700
Shares Outstanding 13,457,625
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Week In Review: Mundipharma Considers $1 Billion Sale Of China Operations
Mundipharma is considering selling its China operations in a deal that could be worth $1 billion. Additionally, Oramed Pharma plans to form a $60 million JV with Hefei Tianhui Biotech to commercialize... 
Via Talk Markets
Week In Review: Novartis In $1 Billion Deal For DTx Pharma
Novartis signed a $1 billion agreement to acquire DTx Pharma, a preclinical San-Diego company developing siRNA therapies for neuroscience indications. Meanwhile, Zhuhai Biotheus formed a far-reaching... 
Via Talk Markets

Performance

YTD
+16.85%
+16.85%
1 Month
-13.65%
-13.65%
3 Month
-23.76%
-23.76%
6 Month
+18.13%
+18.13%
1 Year
-17.94%
-17.94%

More News

Read More
CASI Pharmaceuticals: Q1 Earnings Insights
Via Benzinga
CASI Pharmaceuticals Earnings Perspective: Return On Capital Employed
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
CASI Pharmaceuticals's Return On Capital Employed Insights
Via Benzinga
Recap: CASI Pharmaceuticals Q2 Earnings
Via Benzinga
Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday
Via Benzinga
Week In Review: Sino Biopharma Subsidiary Enters $307 Million Agreement For Rights To NASH Candidate
Via Talk Markets
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Week In Review: Beijing BoomRay Closes $43 Million A Round For Novel Radionuclide Drugs
Via Talk Markets
$2.2 Million Bet On Terns Pharmaceuticals? Check Out These 4 Penny Stocks Insiders Are Buying
Via Benzinga
CASI Pharmaceuticals Earnings Perspective: Return On Capital Employed
Via Benzinga
CASI Pharmaceuticals And 2 Other Stocks Under $4 Insiders Are Aggressively Buying
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Earnings Scheduled For August 12, 2022
Via Benzinga
CASI Pharmaceuticals Earnings: A Preview
Via Benzinga
This Technology Stock Jumped 55% Following Q2 Results; Here Are 96 Biggest Movers From Yesterday
Via Benzinga
Why FlexShopper Surged Over 47%; Here Are 104 Biggest Movers From Yesterday
Via Benzinga
Why Matterport Is Trading Higher By Around 25%, Here Are 73 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why Is Yellow Trading Higher By 33%: Here Are 48 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Week In Review: Sequoia China Raises $9 Billion For Healthcare And Technology Investments
Via Talk Markets
67 Biggest Movers From Yesterday
Via Benzinga
45 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.